Home LiteratureArticle Details
PMID: 7923157 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy.

Cancer research ·Vol. 54 ·No. 20 ·1994-10-15 ·Pages 5301-9

Vitetta ES, Uhr JW

Abstract

暂无摘要

MeSH Terms
Animals Antibodies, Monoclonal/immunology,therapeutic use B-Lymphocytes/immunology Humans Immunoglobulin G/therapeutic use Lymphoma, B-Cell/immunology Mice Mice, Nude Mice, SCID Neoplasms/immunology,therapy Receptor, ErbB-2/immunology Receptors, Immunologic/immunology Signal Transduction
Chemicals
Antibodies, Monoclonal Immunoglobulin G Receptors, Immunologic Receptor, ErbB-2
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Vitetta E S
Cancer Immunobiology Center, University of Texas Southwestern Medical Center at Dallas 75235-8576.
Uhr J W
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1994-10-15
Pages
5301-9
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NCI NIH HHS · CA-28149 · United States
NCI NIH HHS · CA-41087 · United States
External Links
PubMed source View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2